We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Work begins on £6million state-of-the-art surgical facility

Work has begun on a new £6 million state-of-the-art hybrid endovascular theatre suite set to transform the treatment of patients undergoing minimally invasive cardiovascular procedures at Central Manchester University Hospitals NHS Foundation Trust.

This will be the first hospital in the UK to have two adjacent fully hybrid theatres utilising a robotic imaging system with fully flexible theatre table. Only a few such facilities exist world-wide.

Situated in Manchester Royal Infirmary, the two theatres will provide a dedicated facility with state-of-the-art technology. This includes high definition imaging with a robotic arm as well as facilities for traditional surgery all in one place.  The hybrid suite will provide better facilities where existing techniques can be performed more efficiently and safely. It will also enable new innovative techniques and treatments to be carried out that are not currently possible.

Minimally invasive procedures are fast becoming the preferred technique for many patients and doctors. Our Trust has many acknowledged leaders in this field. Procedures are performed through tiny openings rather than one large cut, avoiding the need for open surgery. This means patients coming to Manchester Royal Infirmary for their treatment will have a lower chance of infection, a quicker recovery time and less risk of blood loss, pain and scarring.

Mr David Murray, Consultant Vascular Surgeon at Manchester Royal Infirmary said: "This facility will be a fantastic resource for the people of Manchester and the North West. It will allow us to perform complex procedures in a safer environment and will bring a great many benefits to our patients. Minimally invasive treatments will allow patients to have safer surgery and recover much faster. This really is the cutting edge of technology and we are very excited about the future"

The new hybrid suite will be used primarily for vascular and cardiac surgery but will also be used for other specialties such as urology and major trauma.

The new theatres are due for completion April 2014.